1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Cymbalta (Duloxetine) 1.2.3 Savella (Milnacipran) 1.2.4 Lyrica (Pregabalin) 1.2.5 Pancuronium 1.2.6 Others 1.3 Market by Application 1.3.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Household 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Fibromyalgia Treatment Drug Market Perspective (2017-2028) 2.2 Fibromyalgia Treatment Drug Growth Trends by Region 2.2.1 Fibromyalgia Treatment Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Fibromyalgia Treatment Drug Historic Market Size by Region (2017-2022) 2.2.3 Fibromyalgia Treatment Drug Forecasted Market Size by Region (2023-2028) 2.3 Fibromyalgia Treatment Drug Market Dynamics 2.3.1 Fibromyalgia Treatment Drug Industry Trends 2.3.2 Fibromyalgia Treatment Drug Market Drivers 2.3.3 Fibromyalgia Treatment Drug Market Challenges 2.3.4 Fibromyalgia Treatment Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Fibromyalgia Treatment Drug Players by Revenue 3.1.1 Global Top Fibromyalgia Treatment Drug Players by Revenue (2017-2022) 3.1.2 Global Fibromyalgia Treatment Drug Revenue Market Share by Players (2017-2022) 3.2 Global Fibromyalgia Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Fibromyalgia Treatment Drug Revenue 3.4 Global Fibromyalgia Treatment Drug Market Concentration Ratio 3.4.1 Global Fibromyalgia Treatment Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Treatment Drug Revenue in 2021 3.5 Fibromyalgia Treatment Drug Key Players Head office and Area Served 3.6 Key Players Fibromyalgia Treatment Drug Product Solution and Service 3.7 Date of Enter into Fibromyalgia Treatment Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Fibromyalgia Treatment Drug Breakdown Data by Type 4.1 Global Fibromyalgia Treatment Drug Historic Market Size by Type (2017-2022) 4.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2023-2028) 5 Fibromyalgia Treatment Drug Breakdown Data by Application 5.1 Global Fibromyalgia Treatment Drug Historic Market Size by Application (2017-2022) 5.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Fibromyalgia Treatment Drug Market Size (2017-2028) 6.2 North America Fibromyalgia Treatment Drug Market Size by Type 6.2.1 North America Fibromyalgia Treatment Drug Market Size by Type (2017-2022) 6.2.2 North America Fibromyalgia Treatment Drug Market Size by Type (2023-2028) 6.2.3 North America Fibromyalgia Treatment Drug Market Share by Type (2017-2028) 6.3 North America Fibromyalgia Treatment Drug Market Size by Application 6.3.1 North America Fibromyalgia Treatment Drug Market Size by Application (2017-2022) 6.3.2 North America Fibromyalgia Treatment Drug Market Size by Application (2023-2028) 6.3.3 North America Fibromyalgia Treatment Drug Market Share by Application (2017-2028) 6.4 North America Fibromyalgia Treatment Drug Market Size by Country 6.4.1 North America Fibromyalgia Treatment Drug Market Size by Country (2017-2022) 6.4.2 North America Fibromyalgia Treatment Drug Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Fibromyalgia Treatment Drug Market Size (2017-2028) 7.2 Europe Fibromyalgia Treatment Drug Market Size by Type 7.2.1 Europe Fibromyalgia Treatment Drug Market Size by Type (2017-2022) 7.2.2 Europe Fibromyalgia Treatment Drug Market Size by Type (2023-2028) 7.2.3 Europe Fibromyalgia Treatment Drug Market Share by Type (2017-2028) 7.3 Europe Fibromyalgia Treatment Drug Market Size by Application 7.3.1 Europe Fibromyalgia Treatment Drug Market Size by Application (2017-2022) 7.3.2 Europe Fibromyalgia Treatment Drug Market Size by Application (2023-2028) 7.3.3 Europe Fibromyalgia Treatment Drug Market Share by Application (2017-2028) 7.4 Europe Fibromyalgia Treatment Drug Market Size by Country 7.4.1 Europe Fibromyalgia Treatment Drug Market Size by Country (2017-2022) 7.4.2 Europe Fibromyalgia Treatment Drug Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size (2017-2028) 8.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type 8.2.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Fibromyalgia Treatment Drug Market Share by Type (2017-2028) 8.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application 8.3.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Fibromyalgia Treatment Drug Market Share by Application (2017-2028) 8.4 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region 8.4.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Fibromyalgia Treatment Drug Market Size (2017-2028) 9.2 Latin America Fibromyalgia Treatment Drug Market Size by Type 9.2.1 Latin America Fibromyalgia Treatment Drug Market Size by Type (2017-2022) 9.2.2 Latin America Fibromyalgia Treatment Drug Market Size by Type (2023-2028) 9.2.3 Latin America Fibromyalgia Treatment Drug Market Share by Type (2017-2028) 9.3 Latin America Fibromyalgia Treatment Drug Market Size by Application 9.3.1 Latin America Fibromyalgia Treatment Drug Market Size by Application (2017-2022) 9.3.2 Latin America Fibromyalgia Treatment Drug Market Size by Application (2023-2028) 9.3.3 Latin America Fibromyalgia Treatment Drug Market Share by Application (2017-2028) 9.4 Latin America Fibromyalgia Treatment Drug Market Size by Country 9.4.1 Latin America Fibromyalgia Treatment Drug Market Size by Country (2017-2022) 9.4.2 Latin America Fibromyalgia Treatment Drug Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size (2017-2028) 10.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type 10.2.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Fibromyalgia Treatment Drug Market Share by Type (2017-2028) 10.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application 10.3.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Fibromyalgia Treatment Drug Market Share by Application (2017-2028) 10.4 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country 10.4.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Fibromyalgia Treatment Drug Introduction 11.1.4 Pfizer Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.1.5 Pfizer Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Fibromyalgia Treatment Drug Introduction 11.2.4 Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.2.5 Eli Lilly Recent Developments 11.3 Actavis Generics 11.3.1 Actavis Generics Company Details 11.3.2 Actavis Generics Business Overview 11.3.3 Actavis Generics Fibromyalgia Treatment Drug Introduction 11.3.4 Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.3.5 Actavis Generics Recent Developments 11.4 Merck Sharp and Dohme 11.4.1 Merck Sharp and Dohme Company Details 11.4.2 Merck Sharp and Dohme Business Overview 11.4.3 Merck Sharp and Dohme Fibromyalgia Treatment Drug Introduction 11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.4.5 Merck Sharp and Dohme Recent Developments 11.5 Daiichi Sankyo 11.5.1 Daiichi Sankyo Company Details 11.5.2 Daiichi Sankyo Business Overview 11.5.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction 11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.5.5 Daiichi Sankyo Recent Developments 11.6 Innovative Med Concepts 11.6.1 Innovative Med Concepts Company Details 11.6.2 Innovative Med Concepts Business Overview 11.6.3 Innovative Med Concepts Fibromyalgia Treatment Drug Introduction 11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.6.5 Innovative Med Concepts Recent Developments 11.7 Meda 11.7.1 Meda Company Details 11.7.2 Meda Business Overview 11.7.3 Meda Fibromyalgia Treatment Drug Introduction 11.7.4 Meda Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.7.5 Meda Recent Developments 11.8 Meiji Seika 11.8.1 Meiji Seika Company Details 11.8.2 Meiji Seika Business Overview 11.8.3 Meiji Seika Fibromyalgia Treatment Drug Introduction 11.8.4 Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.8.5 Meiji Seika Recent Developments 11.9 Switch Biotech 11.9.1 Switch Biotech Company Details 11.9.2 Switch Biotech Business Overview 11.9.3 Switch Biotech Fibromyalgia Treatment Drug Introduction 11.9.4 Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.9.5 Switch Biotech Recent Developments 11.10 Theravance 11.10.1 Theravance Company Details 11.10.2 Theravance Business Overview 11.10.3 Theravance Fibromyalgia Treatment Drug Introduction 11.10.4 Theravance Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.10.5 Theravance Recent Developments 11.11 Zynerba Pharmaceuticals 11.11.1 Zynerba Pharmaceuticals Company Details 11.11.2 Zynerba Pharmaceuticals Business Overview 11.11.3 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Introduction 11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.11.5 Zynerba Pharmaceuticals Recent Developments 11.12 Tonix Pharmaceuticals Holding Corp. (TNXP) 11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details 11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview 11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Introduction 11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments 11.13 Daiichi Sankyo 11.13.1 Daiichi Sankyo Company Details 11.13.2 Daiichi Sankyo Business Overview 11.13.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction 11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.13.5 Daiichi Sankyo Recent Developments 11.14 Forest Pharmaceuticals, Inc. 11.14.1 Forest Pharmaceuticals, Inc. Company Details 11.14.2 Forest Pharmaceuticals, Inc. Business Overview 11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Introduction 11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.14.5 Forest Pharmaceuticals, Inc. Recent Developments 11.15 Boehringer Ingelheim GmbH 11.15.1 Boehringer Ingelheim GmbH Company Details 11.15.2 Boehringer Ingelheim GmbH Business Overview 11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Introduction 11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.15.5 Boehringer Ingelheim GmbH Recent Developments 11.16 Pierre Fabre Medicament 11.16.1 Pierre Fabre Medicament Company Details 11.16.2 Pierre Fabre Medicament Business Overview 11.16.3 Pierre Fabre Medicament Fibromyalgia Treatment Drug Introduction 11.16.4 Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2017-2022) 11.16.5 Pierre Fabre Medicament Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Cymbalta (Duloxetine) Table 3. Key Players of Savella (Milnacipran) Table 4. Key Players of Lyrica (Pregabalin) Table 5. Key Players of Pancuronium Table 6. Key Players of Others Table 7. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Fibromyalgia Treatment Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Fibromyalgia Treatment Drug Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Fibromyalgia Treatment Drug Market Share by Region (2017-2022) Table 11. Global Fibromyalgia Treatment Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Fibromyalgia Treatment Drug Market Share by Region (2023-2028) Table 13. Fibromyalgia Treatment Drug Market Trends Table 14. Fibromyalgia Treatment Drug Market Drivers Table 15. Fibromyalgia Treatment Drug Market Challenges Table 16. Fibromyalgia Treatment Drug Market Restraints Table 17. Global Fibromyalgia Treatment Drug Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Fibromyalgia Treatment Drug Revenue Share by Players (2017-2022) Table 19. Global Top Fibromyalgia Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment Drug as of 2021) Table 20. Ranking of Global Top Fibromyalgia Treatment Drug Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Fibromyalgia Treatment Drug Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Fibromyalgia Treatment Drug Product Solution and Service Table 24. Date of Enter into Fibromyalgia Treatment Drug Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2017-2022) Table 28. Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2023-2028) Table 30. Global Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Fibromyalgia Treatment Drug Revenue Share by Application (2017-2022) Table 32. Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Fibromyalgia Treatment Drug Revenue Share by Application (2023-2028) Table 34. North America Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Fibromyalgia Treatment Drug Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Fibromyalgia Treatment Drug Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 64. Pfizer Company Details Table 65. Pfizer Business Overview Table 66. Pfizer Fibromyalgia Treatment Drug Product Table 67. Pfizer Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 68. Pfizer Recent Developments Table 69. Eli Lilly Company Details Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Fibromyalgia Treatment Drug Product Table 72. Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 73. Eli Lilly Recent Developments Table 74. Actavis Generics Company Details Table 75. Actavis Generics Business Overview Table 76. Actavis Generics Fibromyalgia Treatment Drug Product Table 77. Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 78. Actavis Generics Recent Developments Table 79. Merck Sharp and Dohme Company Details Table 80. Merck Sharp and Dohme Business Overview Table 81. Merck Sharp and Dohme Fibromyalgia Treatment Drug Product Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 83. Merck Sharp and Dohme Recent Developments Table 84. Daiichi Sankyo Company Details Table 85. Daiichi Sankyo Business Overview Table 86. Daiichi Sankyo Fibromyalgia Treatment Drug Product Table 87. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 88. Daiichi Sankyo Recent Developments Table 89. Innovative Med Concepts Company Details Table 90. Innovative Med Concepts Business Overview Table 91. Innovative Med Concepts Fibromyalgia Treatment Drug Product Table 92. Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 93. Innovative Med Concepts Recent Developments Table 94. Meda Company Details Table 95. Meda Business Overview Table 96. Meda Fibromyalgia Treatment Drug Product Table 97. Meda Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 98. Meda Recent Developments Table 99. Meiji Seika Company Details Table 100. Meiji Seika Business Overview Table 101. Meiji Seika Fibromyalgia Treatment Drug Product Table 102. Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 103. Meiji Seika Recent Developments Table 104. Switch Biotech Company Details Table 105. Switch Biotech Business Overview Table 106. Switch Biotech Fibromyalgia Treatment Drug Product Table 107. Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 108. Switch Biotech Recent Developments Table 109. Theravance Company Details Table 110. Theravance Business Overview Table 111. Theravance Fibromyalgia Treatment Drug Product Table 112. Theravance Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 113. Theravance Recent Developments Table 114. Zynerba Pharmaceuticals Company Details Table 115. Zynerba Pharmaceuticals Business Overview Table 116. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product Table 117. Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 118. Zynerba Pharmaceuticals Recent Developments Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 123. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments Table 124. Daiichi Sankyo Company Details Table 125. Daiichi Sankyo Business Overview Table 126. Daiichi Sankyo Fibromyalgia Treatment Drug Product Table 127. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 128. Daiichi Sankyo Recent Developments Table 129. Forest Pharmaceuticals, Inc. Company Details Table 130. Forest Pharmaceuticals, Inc. Business Overview Table 131. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product Table 132. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 133. Forest Pharmaceuticals, Inc. Recent Developments Table 134. Boehringer Ingelheim GmbH Company Details Table 135. Boehringer Ingelheim GmbH Business Overview Table 136. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product Table 137. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 138. Boehringer Ingelheim GmbH Recent Developments Table 139. Pierre Fabre Medicament Company Details Table 140. Pierre Fabre Medicament Business Overview Table 141. Pierre Fabre Medicament Fibromyalgia Treatment Drug Product Table 142. Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million) Table 143. Pierre Fabre Medicament Recent Developments Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Global Fibromyalgia Treatment Drug Market Share by Type: 2021 VS 2028 Figure 2. Cymbalta (Duloxetine) Features Figure 3. Savella (Milnacipran) Features Figure 4. Lyrica (Pregabalin) Features Figure 5. Pancuronium Features Figure 6. Others Features Figure 7. Global Fibromyalgia Treatment Drug Market Share by Application: 2021 VS 2028 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Household Case Studies Figure 11. Others Case Studies Figure 12. Fibromyalgia Treatment Drug Report Years Considered Figure 13. Global Fibromyalgia Treatment Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Fibromyalgia Treatment Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Fibromyalgia Treatment Drug Market Share by Region: 2021 VS 2028 Figure 16. Global Fibromyalgia Treatment Drug Market Share by Players in 2021 Figure 17. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment Drug as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Drug Revenue in 2021 Figure 19. North America Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028) Figure 21. North America Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028) Figure 22. North America Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028) Figure 23. United States Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028) Figure 27. Europe Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028) Figure 28. Europe Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028) Figure 29. Germany Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific Fibromyalgia Treatment Drug Market Size Share by Region (2017-2028) Figure 39. China Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 45. Latin America Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028) Figure 47. Latin America Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028) Figure 48. Latin America Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028) Figure 49. Mexico Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028) Figure 55. Turkey Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 59. Eli Lilly Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 60. Actavis Generics Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 61. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 62. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 63. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 64. Meda Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 65. Meiji Seika Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 66. Switch Biotech Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 67. Theravance Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 68. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 69. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 70. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 71. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 72. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 73. Pierre Fabre Medicament Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Pfizer Eli Lilly Actavis Generics Merck Sharp and Dohme Daiichi Sankyo Innovative Med Concepts Meda Meiji Seika Switch Biotech Theravance Zynerba Pharmaceuticals Tonix Pharmaceuticals Holding Corp. (TNXP) Daiichi Sankyo Forest Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Pierre Fabre Medicament